HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
Broadly neutralizing antibody (bnAb) induction is a high priority for effective HIV-1 vaccination. VRC01-class bnAbs that target the CD4 binding site (CD4bs) of trimeric HIV-1 envelope (Env) glycoprotein spikes are particularly attractive to elicit because of their extraordinary breadth and potency...
Main Authors: | Labranche, CC, McGuire, AT, Gray, MD, Behrens, S, Zhou, T, Sattentau, QJ, Peacock, J, Eaton, A, Greene, K, Gao, H, Tang, H, Perez, LG, Saunders, KO, Mascola, JR, Haynes, BF, Stamatatos, L, Montefiori, DC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2018
|
Similar Items
-
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
by: Steichen, Jon M., et al.
Published: (2017) -
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
by: LaBranche, C, et al.
Published: (2019) -
Emission trading with profit-neutral permit allocations
by: Quah, J, et al.
Published: (2012) -
Emissions Trading with Profit-Neutral Permit Allocations.
by: Hepburn, C, et al.
Published: (2008) -
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
by: Pejchal, R, et al.
Published: (2011)